Table 5.
Incremental Cost Effectiveness Ratios (ICERs) for Voucher CM vs. ST and Prize CM vs. STa
| Voucher CM vs. ST ($) | Prize CM vs. ST ($) | |
|---|---|---|
| LDA during treatment | 212 (154, 470) | 166 (128, 278) |
| # of negative specimens during treatment | 156 (108, 665) | 121 (93, 230) |
ST = standard treatment; LDA = longest duration abstinent
Values represent ICERs with 95% confidence intervals (parentheses)